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Objective: To describe the use of therapeutic plasma exchange (TPE) in the treatment
of flunixin meglumine overdose in a cria.
Case Summary: A 3-day-old alpaca cria was diagnosed with ureteral obstruction
and agenesis resulting in severe bilateral hydronephrosis. During hospitalization, the
cria inadvertently received a flunixin meglumine overdose of >65 mg/kg. Here, we
report the use of lipid emulsion and TPE to mitigate flunixin meglumine toxicosis. TPE
appeared to prevent any flunixin-induced kidney or gastrointestinal injury, even in a
patient with congenital defects of the urinary tract.
New Information Provided: This is the first report of the use of TPE in a cria.
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1 CASE SUMMARY
A male alpaca cria weighing 7.6 kg was presented to a university
teaching hospital at 72 hours of age for straining presumed to be
due to meconium impaction. Parturition was not witnessed, but the
cria appeared normal after delivery and was nursing well. The 8-year-
old hembra was clinically normal. Upon presentation, the cria was
bright, alert, and responsive with normal vital parameters (heart rate,
144/min; respiratory rate, 62/min; temperature, 39.3◦C [102.7◦F]).
Physical examination was consistent with a 72-hour-old term cria,
with the exception of a slightly kyphotic appearance and a mass in
the mid/caudal abdomen appreciated on palpation. Initial bloodwork
revealed a leukocytosis (23.28 × 109/L [23.28k/µL]; reference inter-
val [RI], 8–22 × 109/L [8k–22k/µL]), with an increased creatinine
(176.8 µmol/L [2 mg/dL]; RI, 80–150 µmol/L [0.9–1.7 mg/dL]) and
Abbreviations: GFR, glomerular filtration rate; ILE, intravenous lipid emulsion; RI, reference
interval; TPE, therapeutic plasma exchange
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urea (15.7 mmol/L [44 mg/dL]; RI, 5–10 mmol/L [13–28 mg/dL]). The
remainder of the CBC and serum biochemistry was unremarkable. The
cria had adequate passive transfer of antibodies (immunoglobulin G =
11.25 g/L [1,125mg/dL]).
Abdominal radiography revealed a right-sided, large, ovoid opaque
soft tissue structure in the caudodorsal abdomen, which resulted in
ventral displacement of the colon and cranial and left lateral dis-
placement of the gastric compartments and spiral colon. To further
investigate the abnormalities, abdominal ultrasonography was per-
formed that revealed a markedly enlarged right kidney with severe
hydronephrosis and a hydroureter. The left kidney also had severe
hydronephrosis but retained more cortex than the contralateral side.
Further assessment of structural defects using a computed tomogra-
phy scan confirmed severe bilateral hydronephrosis and hydroureter
that was worse on the right. Intravenously administered iodinated
mediumwasnot identifiedwithin thedilated right renal pelvis orwithin
the right ureter; therefore, right kidney function was thought to be
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poor. A small volume of contrast medium pooled within the gravity-
dependent aspect of the left renal pelvis and ureter. The primary dif-
ferential diagnosis was partial left and complete right distal ureteral
obstructions. A functional assessment of the urinary system showed
normal fractional electrolyte excretions aside from potassium (sodium,
0.32%; potassium, 4.78%; chloride, 0.74%; phosphorus, 0.28%) and
isosthenuric urine (urine-specific gravity, 1.013).
To further assess the function of both kidneys prior to consider-
ing surgical intervention, nuclear scintigraphy was performed using
3.5 miC of 99mTc-DTPA (IV) with dynamic acquisition of 1 frame
per second for 5 minutes. The excretion phase was evaluated after
administration of 1.5 mL furosemide IV with additional acquisition for
over 3 minutes. Calculated global glomerular filtration rate (GFR) was
3.4 mL/kg/min; individual GFR of the right kidney was calculated at
1mL/kg/min (30%), and the left kidneywas calculated at 2.4mL/kg/min
(70%). The calculated GFRs, specifically the global GFR and right kid-
ney GFR, were thought to be overestimated due to difficulty in delin-
eating clear regions of interest given the severe hydronephrosis and
secondary organ crowding. TheGFR study concluded that themajority
of kidney function (70%)was provided by the left kidney. The presump-
tive diagnosis based on imaging studies was left ureteral obstruction
due to ectopia and right ureteral obstruction due to distal ureteral age-
nesis.
During the courseof hospitalization, bilateral pyelocentesiswas also
performed under ultrasound guidance in order to reduce the size of
the kidneys and ease pressure on the remaining parenchyma. The right
yielded 310 mL and the left yielded 250 mL of urine. Analysis of the
urine sample showed increased protein and RBCs (possibly from sam-
pling), and a urine-specific gravity of 1.012. Culture yielded no growth.
On day 5 of hospitalization, the cria developed severe tachypnea
and dyspnea with peracute respiratory distress after inadvertent IV
flunixinmegluminea administration (500mg;>65mg/kg). Flow-byoxy-
gen via a face mask was administered due to the initial respiratory dis-
tress. Arterial blood gas analysis performed on 100% oxygenwithin 10
minutes indicated metabolic acidosis with respiratory compensation,
with an appropriate PaO2 (237.8 mm Hg), decreased PaCO2 (23.7 mm
Hg), normal pH (7.455), low bicarbonate (16.8 mmol/L), and increased
plasma lactate (6.5 mmol/L). Given the lipophilic nature of flunixin, IV
lipid infusion therapy was initiated about 1 hour after the overdose.
The cria was treated with 2 mL/kg of lipid emulsionb (IV) over 15 min-
utes, followed by a continuous rate infusion of 0.25mL/kg/min over the
subsequent 30 minutes. Therapeutic plasma exchange (TPE) was cho-
sen to remove asmuch of the highly protein-bound drug as possible.
In addition to the 14-Ga jugular IV catheterc already present, a
second jugular IV catheter (8-Fr × 10 cm)d was placed using a mod-
ified Seldinger technique after midazolam sedation to facilitate the
prescribed plasma exchange. Placement of the dialysis catheter was
confirmed with right lateral thoracic radiography. The plasma volume
of the cria was calculated to be approximately 387 mL based on an
approximated total plasma volume for a cria to be total blood volume
70mL/kg× 1 –HCT (0.7), with the goal to exchange at least 1.5 plasma
volumes, which should result in a removal of 78% of the toxin, or more,
if tolerated by the cria.
TPEwas initiated about 4 hours after overdose andperformedusing
an extracorporeal membrane-based device.e A TPE 2000 cartridgef
was employed. This polypropylene filter has a surface area of 0.35 M2
and a priming volume of 125 mL and a plasma filter volume of 41 mL.
This resulted in anextracorporeal circuit volumeof166mL. Theplasma
was exchanged with a replacement fluid consisting of 1 unit (500 mL)
of 3%hydroxyethyl starchg dilutewith 0.9% saline and 2 units (approx-
imately 600mL) of hyperimmune Lama glama plasma.hMidazolamwas
given intermittently IV and titrated to effect to keep the cria amenable
to the procedure. Over the course of treatment, activated coagula-
tion time and venous blood gases were measured to monitor heparin
administration and electrolytes, respectively. Pre- and post-TPE blood
samples were drawn and frozen, and serum samples subsequently sent
for toxicology analysis.i Because this was a neonate, and an expected
large amount of antibodies from passive transfer would possibly be
removed and only one third of colloid administered at the start of
exchange is typically present at the end of the session, we elected to
provide 500 mL of hetastarch first and follow with 2 units of hyperim-
mune plasma. In total, 1,064mL of replacement fluid was provided (2.5
plasmavolumesexchanged) to removeanestimated92%of the flunixin
(equating to removal of about 60mg/kg, leaving 5mg/kg flunixin).
After TPE, the cria was returned to his hembra and maintained on
2 mL/kg/h Plasmalyte-Aj (IV) with intermittent doses of furosemide to
encourage urine production. Othermedications administered included
2.2mg/kg ceftiofur sodiumk (IV) every 12 hours due to havingmultiple
IV catheters placed, and 1 mg/kg pantoprazole (IV) every 24 hours to
prevent third compartment ulcers secondary to flunixin toxicity. Serial
hematologyandbiochemistryprofileswereperformedduringhospital-
ization. Coagulation assessment (clotting times, platelet count, throm-
boelastography) was unremarkable apart from a slightly prolonged
activated partial thromboplastin time (25.9 s [RI, 8–22 s]). Using BUN,
creatinine, potassium, and sodium plasma concentrations as indicators
of kidney function, no change was attributed to flunixin meglumine
toxicosis after overdose (Figure 1). In addition, no signs of gastroin-
testinal ulceration became apparent, with the cria continuing to nurse
well from the dam throughout. The cria was discharged 7 days post-
flunixin overdose with stable kidney function, albeit compromised due
to ureteral stenosis and agenesis, as clients wanted more time to con-
sider surgery. Although lost to follow-upby the hospital, 3months after
discharge the cria was reported to have not undergone surgery and
appeared to be clinically well.
Toxicology analysish was performed using a liquid–liquid extraction
of sample at pH 3.3 with a 1:1:1 mixture of hexane, diethyl ether, and
dichloromethane. The samplewas evaporated to dryness and reconsti-
tuted in 50 µL ethyl acetate, then analyzed via gas chromatography–
mass spectrometry with the flunixin peak area plotted against a
prespiked standard curve prepared in equine plasma. This confirmed
flunixin overdose as the presence of pre-TPE flunixin was found,
although the exact concentration was unable to be obtained due to
insufficient sample; however, it was estimated to be about 13 times
higher than post-TPE flunixin concentration, which was 4.8 µg/mL. Per
the manufacturer, administering 3–5 times the recommended dosage
of flunixin meglumine (1 mg/kg) did not result in any apparent adverse
DIXON ET AL. 523
F IGURE 1 Renal function assessed by sodium (Na+), BUN, potassium (K+), and creatinine (Creat) concentrations in plasma in a cria before and
after flunixin meglumine overdose
effects in adult horses or cattle (Banamine product insert). However,
flunixin-induced renal crest necrosis has been reported in an adult
horse, even at the recommended dosage.1 Neonatal foals receiving
6.6 mg/kg flunixin meglumine for 5 days showed significant gastroin-
testinal ulceration on necropsy,2 although treating our cria with TPE
seems to have prevented any such ulceration clinically. No additional
diagnostics were performed to rule out subclinical ulcerations. To date,
flunixin has been poorly studied in camelids. Published data indicate
that flunixin is protein-bound to a higher degree and is cleared at a
lower rate in llamas than in other studied species,3 which justified our
decision to proceedwith TPE despite the initial intravenous lipid emul-
sion (ILE) therapy. Although the reduction in flunixin from about 62
to 4.8 µg/mL over 7 hours could be explained by native metabolism
in a healthy adult llama where the drug has an elimination half-life
of 1.5 hours,3 this is not expected in the current case. Neonatal foals
have slower flunixin clearance compared with adult horses,4 and the
decreased renal function in this cria further decreased the expected
drug clearance.
The treatment of flunixin meglumine toxicity in the current case
was complicated by preexisting urinary tract abnormalities. The bilat-
eral hydronephrosis and ureteral abnormalities were severe in this
cria but consistent with previously reported congenital abnormali-
ties in camelids. Both ectopic ureters resulting in hydroureter and
hydronephrosis,5,6 and various forms of renal or ureteral agenesis and
aplasia,7–9 have been reported.
ILE therapy was used in the current case while TPE was being
arranged, and therefore its success alone could not be evaluated. ILE
has been described for treatment of a variety of drug toxicities in vet-
erinary patients,10 including goats11 and equines,12–14 and is thought
to be most effective for lipid solute toxicants such as local anesthetics
and ivermectin. ILE has been previously used for treating nonsteroidal
anti-inflammatory drug toxicities in dogs15,16 and so was a reasonable
treatment option in this case.
Although TPE and dialysis modalities are often unavailable to large
animal patients due to their inherent large size and the costs associated
with such treatments, our current report suggests that TPE canbeused
in select cases of highly protein-bound drug toxicosis, including flunixin
overdose, especially when no antidote is available. Renal replacement
therapy has been performed in large animal neonates for acute kid-
ney injury due tooxytetracycline toxicity17 or after resuscitation,18 but
TPE as a treatment for drug overdose has not been previously reported
in large animal species. Even in the face of congenital defects of the
urinary tract, the cria reported here sustained no apparent additional
kidney injury or clinically manifesting gastrointestinal ulceration after
flunixin meglumine overdose after TPE treatment. Although there are
numerous published reports of TPE use in small animals, to our knowl-
edge, this is the first report of such a treatment protocol in a large ani-
mal patient.
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